One Global Service Provider Ltd is a healthcare and technology company built on a deliberate pivot - it began life in 1992 as a synthetic textiles manufacturer, listed on the Bombay Stock Exchange since 1994, then transformed itself completely after a change in management around 2020. It abandoned textiles and re-registered as a provider of healthcare services, later adding IT and software solutions in 2022 so it could sell not just medical products but the digital tools that surround them. The recurring idea is a “One-Stop Solution” - a single platform that brings together medical devices, consumables, diagnostics, and software, with the company’s stated belief that diagnosis is the link between a patient and a cure, and that accuracy, affordability, and accessibility must sit at the centre of everything it does. # Business segments Two engines at different stages - a healthcare trading and services business that generates the revenue, and a younger IT arm that sells software and digital transformation to the same kind of customer, both wrapped around the same one-stop promise. ## 1. Healthcare services: the trading and diagnostics engine **The company buys medical products and sells them to hospitals, government bodies, and healthcare professionals, layering on mass screening and diagnostic expertise - it is a distributor with clinical know-how, not a manufacturer.** - **Buys stock, doesn’t make it** - the largest expense line is “Purchases of Stock-in-Trade,” and the company carries no inventory, which means it operates a buy-and-supply model for medical devices, consumables, reagents, and pharmaceutical formulations rather than producing anything itself. - **Sells to institutions, not individuals** - its customers are hospitals, healthcare professionals, and government bodies running public health programmes, with trade receivables collected typically within 14 to 90 days and a customer base spread across multiple geographies so no single client dominates. - **Diagnostics is the differentiator** - the company provides mass screening and laboratory support services, and its Chairman holds a biomedical engineering degree with a specialisation in nuclear medicine and over 20 years in diagnostics, so the trading business comes with clinical credibility that commodity distributors lack. - **A single online shopfront** - it positions itself as a platform where clients can source everything from equipment to consumables under one roof, which is how it turns a fragmented product range into a convenience story for busy procurement teams. - **Asset-light by design** - property, plant and equipment stood at just Rs. 243.34 Lacs as of March 2025, consisting solely of plant and machinery, and the company has no foreign exchange earnings or technical collaborations, so the business runs on working capital and relationships rather than heavy infrastructure. ## 2. IT and software solutions: the digital layer on top **The company writes software for the same industries it sells medical products to - e-commerce, banking, education, biotechnology - and offers everything from analytics dashboards to the servers that run them.** - **Added by rewriting the rulebook** - in March 2022 the company amended its Memorandum of Association to permit software consultancy, development, and distribution across more than a dozen sectors, turning a healthcare company into a hybrid that can bid for technology contracts. - **Sells code, licences, and hardware** - it develops software applications, resells licences, imports and exports IT products, and provides the servers and routers to host them, so a single contract can cover the digital tool and the box it runs on. - **Data science is the pitch** - its services include analytics, machine learning, artificial intelligence, and statistical inference, which means it can offer hospitals and banks more than a billing system - it can sell pattern-finding tools that sit on top of their data. - **Still early-stage** - the company has not yet incurred expenditure on research and development or taken concrete steps toward technology absorption, though it says it is planning investment, so the IT arm is a capability being built rather than a mature profit centre. # Group structure and partners **The company stands alone - no subsidiaries, no joint ventures, no foreign operations - and has just absorbed its only related entity through a merger designed to put every healthcare asset under one roof.** - **A single-entity structure** - as of the FY25 annual report, One Global Service Provider Ltd has no holding company, no subsidiary, no associate, and no joint venture, and it carries no foreign direct investment or overseas borrowings. - **One merger to consolidate** - its former subsidiary Plus Care Internationals Private Limited, which ran hospitals, diagnostic centres, blood banks, and ambulances, was amalgamated into the company through a scheme approved by the National Company Law Tribunal in March 2025, with an appointed date of January 2023. - **Shares issued, not cash paid** - the merger was settled by issuing 1,202 equity shares of One Global Service Provider for every one share of Plus Care, adding roughly 1.24 crore new shares to the company’s capital and bringing the former subsidiary’s shareholders - including the Chairman - onto the promoter group register. - **Listed infrastructure in place** - shares trade on the BSE, depository services run through both NSDL and CDSL, and the registrar for physical shares is MCS Share Transfer Agent Limited, so the plumbing for a public company is fully operational even while the business itself is being rebuilt.